Congenital dyserythropoietic anemia type II in a newborn with a novel compound heterozygous mutation in the SEC23B: a case report and review of the literature

Zheng Ji1, Li Gao1, Hu Liu1, Peifang Xiao1, Jun Lü1, Jie Li1, Shuiyan Wu1, Shengqin Cheng1, Xinni Bian1, Zhizhuo Du1, Lingjun Kong1, Shaoyan Hu1, Junjie Fan1
1Department of Hematology and Oncology, Soochow University Affiliated Children’s Hospital, Suzhou, People’s Republic of China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Iolascon A, Heimpel H, Wahlin A, Tamary H. Congenital dyserythropoietic anemias: molecular insights and diagnostic approach. Blood. 2013;122:2162–6.

Gambale A, Iolascon A, Andolfo I, Russo R. Diagnosis and management of congenital dyserythropoietic anemias. Expert Rev Hematol. 2016;9:283–96.

Bianchi P, Fermo E, Vercellati C, Boschetti C, Barcellini W, Iurlo A, et al. Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene. Hum Mutat. 2009;30:1292–8.

Schwarz K, Iolascon A, Verissimo F, Trede NS, Horsley W, Chen W, et al. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet. 2009;41:936–40.

Heimpel H, Anselstetter V, Chrobak L, Denecke J, Einsiedler B, Gallmeier K, et al. Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Blood. 2003;102:4576–81.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foste J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17:405–24.

Bianchi P, Schwarz K, Hogel J, Fermo E, Vercellati C, Grosse R, et al. Analysis of a cohort of 101 CDAII patients: description of 24 new molecular variants and genotype-phenotype correlations. Br J Haematol. 2016;175:696–704.

Russo R, Gambale A, Langella C, Andolfo I, Unal S, Iolascon A. Retrospective cohort study of 205 cases with congenital dyserythropoietic anemia type II: definition of clinical and molecular spectrum and identification of new diagnostic scores. Am J Hematol. 2014;89:E169–75.

Musri MM, Venturi V, Ferrer-Cortès X, Romero-Cortadellas L, Hernández G, Leoz P, et al. New cases and mutations in SEC23B gene causing congenital dyserythropoietic anemia type II. Int J Mol Sci. 2023;24(12):9935.

Moreno-Carralero MI, Horta-Herrera S, Morado-Arias M, Ricard-Andrés MP, Lemes-Castellano A, Abio-Calvete M, et al. Clinical and genetic features of con-genital dyserythropoietic anemia (CDA). Eur J Haematol. 2018;101(3):368–78.

Iolascon A, Andolfo I, Russo R. Congenital dyserythropoietic anemias. Blood. 2020;136(11):1274–83.

Iolascon A, Andolfo I, Barcellini W, Corcione F, Garçon L, De Franceschi L, Working Study Group on red cells and iron of the EHA, et al. Recommendations regarding splenectomy in hereditary hemolytic anemias. Haematologica. 2017;102(8):1304–13.

Uygun V, Russo R, Karasu G, Daloğlu H, Iolascon A, Yeşilipek A. Hematopoietic stem cell transplantation in congenital dyserythropoetic anemia type II: a case report and review of the literature. J Pediatr Hematol Oncol. 2020;42(6):e507–10.